Apply

Job Type Full-time Description JOB PURPOSE: · Execute on regulatory strategy of De Novo submissions for AI/ML-based Software as a Medical Device (SaMD) product, including AidaBreast. · Serve as regulatory lead for novel oncology diagnostic technologies integrating genomic and proteomic biomarkers. · Ensure alignment with FDA expectations for Breakthrough Device Designation (BDD), SaMD, and clinical validation requirements. · Collaborate cross-functionally to support development of clinically impactful breast cancer risk assessment tools. ESSENTIAL RESPONSIBILITIES: · Develop and execute regulatory strategies for De Novo and Breakthrough Device submissions. · Author and compile high-quality FDA submissions including device description, intended use, software documentation, and clinical evidence. · Lead FDA interactions including Q-Submissions, Pre-Subs, and deficiency responses. · Translate complex AI/ML algorithms and biomarker data into clear regulatory documentation. · Collaborate with Clinical, Biostatistics, Data Science, and Software teams on validation strategies. · Ensure alignment with QMS and regulatory standards (IEC 62304, ISO 14971). · Support regulatory positioning of prognostic and predictive oncology claims.

Requirements EXPERIENCE & QUALIFICATIONS: · 6+ years regulatory experience in medical devices or digital health. · Direct experience leading De Novo submissions (required). · Experience with SaMD and AI/ML-based algorithms strongly preferred. · Strong knowledge of FDA regulatory frameworks and guidance for SaMD. · Experience with clinical validation of diagnostic or predictive models. Preferred Qualifications · Experience with oncology diagnostics or multi-omic assays. · Familiarity with CLIA/CAP laboratory environments. · Experience with Breakthrough Device Designation submissions. · RAC certification preferred.

EDUCATION: · Bachelor’s degree in science, engineering, or related field (advanced degree preferred). Salary Description $90,000-$140,000 DOE